Ventral and Incisional Hernia Background
Ventral hernias occur through the anterior abdominal wall, most commonly at the umbilicus (umbilical hernia) or at the site of a prior abdominal surgical incision (incisional hernia). Incisional hernias affect 10 to 15 percent of patients who undergo abdominal surgery and are more common after emergency procedures, obese patients, and patients with wound complications after the original surgery. The hernia defect in ventral repairs is typically larger than in inguinal repairs, requiring correspondingly larger mesh implants with proportionally more surface area against bowel.
Why Large Ventral Mesh Failures Are Severe
Large ventral mesh repairs — particularly those using composite devices like Ethicon Physiomesh, Davol Composix E/X, or Atrium C-QUR — place substantial mesh surface in close proximity or direct contact with the bowel and other intra-abdominal organs. When the mesh's anti-adhesion barrier degrades or is absent, extensive adhesions can form across the entire mesh surface. Unlike inguinal mesh adhesions which are spatially limited, large ventral mesh adhesions can bind multiple loops of bowel simultaneously, creating complex obstruction patterns requiring extensive surgical lysis with high risk of bowel injury.
The Physiomesh Recall and Ventral Claims
Ethicon Physiomesh was primarily indicated for laparoscopic ventral hernia repair, and ventral hernia patients constitute a significant proportion of the Ethicon MDL 2753 caseload. Following the 2016 withdrawal, patients who had already received Physiomesh were left without manufacturer support and without an FDA recall compelling explantation. Surgeons were advised to monitor patients but many complications were not identified until years later when patients presented with pain, bowel symptoms, or recurrence. Patients who received Physiomesh for ventral hernia repair should seek legal evaluation regardless of how long ago the surgery occurred.
Related Pages
Davol and C.R. Bard Hernia Mesh Products
Davol Inc. and its parent C.R. Bard (now Becton Dickinson) manufactured the largest portfolio of recalled and litigation-linked hernia mesh products in the United States. Products including 3DMax, Ventralex ST, and the recalled Composix Kugel are at the center of MDL 2846 — one of the largest active medical device MDLs in federal court.
Hernia Mesh Infection Claims
Hernia mesh infection is a devastating complication because bacteria colonize the mesh material in treatment-resistant biofilms, usually requiring complete surgical removal. Mesh design characteristics — including pore size, material composition, and surface coatings — directly affect infection susceptibility, creating strong product liability theories.
Hernia Mesh Settlements — What to Expect
Hernia mesh mass tort settlements are structured as tiered grids based on injury severity, number of revision surgeries, and individual case factors. Understanding how settlement grids work and what factors increase your tier placement helps you evaluate your claim and avoid accepting inadequate offers.
Hernia Mesh Evidence — Building Your Claim
A strong hernia mesh claim rests on three evidentiary pillars: confirmed product identification (which specific mesh was implanted), documented complications in medical records, and expert opinions causally linking the mesh to the injuries. Gathering and preserving this evidence from the moment complications are identified is the single most important step a potential claimant can take.
Ethicon and Johnson and Johnson Hernia Mesh
Ethicon, a Johnson and Johnson subsidiary, manufactured the Physiomesh Flexible Composite — voluntarily withdrawn from global markets in May 2016 after independent registry data revealed reoperation rates two to three times higher than comparator meshes. Ethicon Physiomesh and related product claims are consolidated in MDL 2753 in the District of New Jersey and MCL 616 in New Jersey Superior Court.
Hernia Mesh Complications — What Can Go Wrong
Defective hernia mesh can cause a spectrum of complications from painful but treatable infections to catastrophic bowel perforation and sepsis. Understanding which complications are associated with mesh defects — versus routine surgical risks — is essential for evaluating whether a legal claim exists.
Hernia Mesh Revision Surgery — What It Involves
Hernia mesh revision surgery — including adhesiolysis, partial mesh removal, and complete explantation — is a significantly more complex and dangerous operation than the original hernia repair. The risks, costs, and recovery demands of revision surgery are core elements of damages in hernia mesh litigation.
Hernia Mesh Recall History — What the FDA Found
The FDA has issued safety communications, ordered 522 post-market surveillance studies, and presided over multiple hernia mesh recalls. The regulatory history establishes that manufacturers had notice of mesh complications well before many patients were implanted — a critical element of failure-to-warn and design defect claims.
Inguinal Hernia Mesh Claims
Inguinal hernia mesh repairs are the most common hernia surgery in the United States, accounting for approximately 800,000 procedures annually. The inguinal region's proximity to critical nerves and spermatic cord structures makes mesh complications in this location particularly likely to cause chronic, debilitating pain.
Hernia Mesh MDL 2846 — What You Need to Know
MDL 2846 in the Southern District of Ohio is the federal coordination for all Davol/C.R. Bard hernia mesh cases. With over 20,000 cases and ongoing bellwether trials, understanding how the MDL works is essential for any potential claimant navigating this litigation.
Hernia Mesh Chronic Pain — Inguinodynia Claims
Chronic groin pain (inguinodynia) following hernia mesh repair affects an estimated 10 to 30 percent of patients in some surgical registry studies and is the most common basis for hernia mesh legal claims. Nerve entrapment by mesh fixation devices and mesh contracture are the primary mechanisms. Chronic pain claims are legally cognizable even without revision surgery.
Hernia Mesh (Davol/C.R. Bard) Lawsuit
Hernia mesh litigation is one of the largest ongoing mass tort actions in the United States. Polypropylene mesh devices implanted during inguinal, ventral, and incisional hernia repairs have been associated with a pattern of serious defects — including mesh shrinkage, migration, erosion into adjacent organs, bacterial colonization, and nerve entrapment — that manufacturers knew about for years before disclosing to physicians or patients. The primary defendants include Davol Inc. and its parent C.R. Bard (now part of Becton Dickinson), Ethicon (a Johnson and Johnson subsidiary), Atrium Medical, and Covidien (now part of Medtronic). The federal multidistrict litigation MDL 2846 in the Southern District of Ohio has consolidated thousands of Davol/C.R. Bard claims for coordinated pre-trial proceedings. Separately, Ethicon mesh cases are coordinated in New Jersey Superior Court (MCL 616). Patients who underwent hernia repair surgery and subsequently experienced complications are urged to seek legal evaluation immediately — statutes of limitations are running and evidence must be preserved.
View full case overview